Genetic testing for advanced cancers
Part of Cancer, Genetic & congenital clinical trials.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have one of these cancer types: breast (specific type), lung, ovary, pancreas, prostate, colorectal, melanoma, GIST, thyroid, endometrial, or cholangiocarcinoma.
- If you have breast cancer, it must have spread and not responded to hormone therapy.
- For lung, pancreatic, colorectal, or prostate cancer, the disease must have spread to other parts of the body (metastatic).
- For ovarian cancer, it cannot be the mucinous or borderline type.
- For melanoma, you must have stage 4 or stage 3 that is being removed with surgery.
- For GIST, you need tumor testing for specific genetic changes if it has spread or if you are having surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This study uses genetic testing of your tumor to find specific mutations and match you with targeted therapies, aiming to improve outcomes for advanced cancers with poor prognosis. If you have pancreatic, liver, or triple negative breast cancer and are starting treatment, this trial may help you access personalized treatment options.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
Hear when a new Genetic Predisposition to Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.